-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q2 2025.
- BioNexus Gene Lab Corp Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $0.000, a 100% decline year-over-year.
- BioNexus Gene Lab Corp Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was -$39K, a 379% decline year-over-year.
- BioNexus Gene Lab Corp annual Income Tax Expense (Benefit) for 2024 was -$3.49K, a 83.8% increase from 2023.
- BioNexus Gene Lab Corp annual Income Tax Expense (Benefit) for 2023 was -$21.5K, a 58.8% increase from 2022.
- BioNexus Gene Lab Corp annual Income Tax Expense (Benefit) for 2022 was -$52.3K, a 82% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)